| A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma. |
18006766 |
Clin Cancer Res |
| Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. |
11429699 |
Oncogene |
| An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome. |
16931588 |
J Mol Diagn |
| Aquaporin 1 is overexpressed in lung cancer and stimulates NIH-3T3 cell proliferation and anchorage-independent growth. |
16565507 |
Am J Pathol |
| Assessment of gene promoter hypermethylation for detection of cervical neoplasia. |
16736496 |
Int J Cancer |
| Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. |
11745231 |
Cancer |
| DCC promoter hypermethylation in esophageal squamous cell carcinoma. |
18302152 |
Int J Cancer |
| Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. |
14633692 |
Cancer Res |
| Decreased mitochondrial DNA content in posttreatment salivary rinses from head and neck cancer patients. |
16533782 |
Clin Cancer Res |
| Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. |
17018594 |
Cancer Res |
| Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. |
15192122 |
Mol Cancer Res |
| Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. |
16908936 |
J Clin Oncol |
| Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patients. |
14999140 |
Breast Cancer Res Treat |
| Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. |
11606403 |
Cancer Res |
| Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. |
15073103 |
Clin Cancer Res |
| Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer. |
16263813 |
J Clin Endocrinol Metab |
| Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. |
15814621 |
Clin Cancer Res |
| Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. |
17020408 |
PLoS Med |
| Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations. |
12578990 |
Proc Natl Acad Sci U S A |
| Endothelin B receptor gene hypermethylation in prostate adenocarcinoma. |
12499435 |
J Clin Pathol |
| Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer. |
17534889 |
Int J Cancer |
| Epigenetic silencing of human T (brachyury homologue) gene in non-small-cell lung cancer. |
17980147 |
Biochem Biophys Res Commun |
| Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. |
18172258 |
Clin Cancer Res |
| Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. |
17456604 |
Proc Natl Acad Sci U S A |
| Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions. |
15812243 |
DNA Cell Biol |
| Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. |
12684406 |
Clin Cancer Res |
| Genome-wide promoter analysis uncovers portions of the cancer methylome. |
18413733 |
Cancer Res |
| High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients. |
17947477 |
Clin Cancer Res |
| HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma. |
18234960 |
Mol Cancer Res |
| Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer. |
17016690 |
J Mol Med (Berl) |
| Hypermethylation of the Pendred syndrome gene SLC26A4 is an early event in thyroid tumorigenesis. |
12727855 |
Cancer Res |
| I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. |
12010858 |
Cancer Epidemiol Biomarkers Prev |
| Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. |
11585726 |
Cancer Res |
| Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer. |
17118488 |
Lung Cancer |
| Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers. |
11280771 |
Cancer Res |
| Increased mitochondrial DNA content in saliva associated with head and neck cancer. |
15814624 |
Clin Cancer Res |
| Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. |
15342377 |
Cancer Res |
| Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma. |
17360030 |
Gynecol Oncol |
| LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer. |
16912160 |
Cancer Res |
| Loss of chromosome arms 3p and 9p and inactivation of P16 (INK4a) in normal epithelium of patients with primary lung cancer. |
11550279 |
Genes Chromosomes Cancer |
| Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer. |
15753360 |
Cancer Res |
| LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer. |
17456585 |
Cancer Res |
| Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. |
12727856 |
Cancer Res |
| Methylation status in the promoter region of the human PGP9.5 gene in cancer and normal tissues. |
11448537 |
Cancer Lett |
| Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. |
12114429 |
Clin Cancer Res |
| Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. |
18245469 |
Cancer Res |
| Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. |
11839667 |
Clin Cancer Res |
| Mitochondrial DNA alterations in thyroid cancer. |
12619060 |
J Surg Oncol |
| Mitochondrial DNA as a cancer biomarker. |
15858150 |
J Mol Diagn |
| Mitochondrial DNA content increase in response to cigarette smoking. |
16434581 |
Cancer Epidemiol Biomarkers Prev |
| Mitochondrial DNA mutations in human cancer. |
16892080 |
Oncogene |
| Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer. |
17166268 |
Mol Cancer |
| Mitochondrial mutations in early stage prostate cancer and bodily fluids. |
11526508 |
Oncogene |
| Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer. |
18094415 |
Clin Cancer Res |
| Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study. |
11882817 |
J Thorac Cardiovasc Surg |
| Molecular characteristics of non-small cell lung cancer. |
11752463 |
Proc Natl Acad Sci U S A |
| Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. |
11555585 |
Clin Cancer Res |
| Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer. |
15515012 |
Int J Cancer |
| MT1G hypermethylation is associated with higher tumor stage in prostate cancer. |
15894685 |
Cancer Epidemiol Biomarkers Prev |
| Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. |
11410508 |
Clin Cancer Res |
| O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer. |
11719438 |
Cancer Res |
| Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma. |
15328191 |
Clin Cancer Res |
| Oxidized guanine lesions and hOgg1 activity in lung cancer. |
15856018 |
Oncogene |
| p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study. |
12837832 |
J Natl Cancer Inst |
| PGP9.5 methylation in diffuse-type gastric cancer. |
16585221 |
Cancer Res |
| PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. |
15930319 |
Cancer Res |
| Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma. |
17592394 |
Laryngoscope |
| Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy. |
16322291 |
Clin Cancer Res |
| Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. |
11448914 |
Clin Cancer Res |
| Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. |
11221887 |
Cancer Res |
| Proteomic analysis of cancer-cell mitochondria. |
14570046 |
Nat Rev Cancer |
| Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. |
11717336 |
J Natl Cancer Inst |
| Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. |
16849682 |
J Natl Cancer Inst |
| Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. |
11507047 |
Cancer Res |
| Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. |
11809682 |
Cancer Res |
| Quantitative assessment of promoter methylation profiles in thyroid neoplasms. |
15840741 |
J Clin Endocrinol Metab |
| Quantitative detection of promoter hypermethylation as a biomarker of acute kidney injury during transplantation. |
17175292 |
Transplant Proc |
| Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. |
15289362 |
Cancer Res |
| Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. |
12475696 |
Urology |
| Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies. |
14600096 |
J Natl Cancer Inst |
| Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. |
12576869 |
J Urol |
| Quantitative GSTP1 methylation levels correlate with Gleason grade and tumor volume in prostate needle biopsies. |
15126784 |
J Urol |
| Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions. |
17549626 |
Breast Cancer Res Treat |
| Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. |
16170165 |
J Clin Oncol |
| Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker. |
15217932 |
Clin Cancer Res |
| RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma. |
16619251 |
Int J Cancer |
| Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations. |
12917199 |
Cancer Epidemiol Biomarkers Prev |
| Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. |
17405999 |
J Natl Cancer Inst |
| Targeting human 8-oxoguanine DNA glycosylase to mitochondria protects cells from 2-methoxyestradiol-induced-mitochondria-dependent apoptosis. |
18246124 |
Oncogene |
| Targeting of mutant hogg1 in mammalian mitochondria and nucleus: effect on cellular survival upon oxidative stress. |
17018150 |
BMC Cancer |
| The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. |
15123581 |
Genome Res |
| The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. |
16862168 |
Oncogene |
| Tissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer. |
18082200 |
J Urol |
